Journal of Occupational and Environmental Medicine · 1998 · 36 citations · 13 references
MedicineMolecular GeneticsToxicologyDrug MetabolismEnzymologyMetabolismCarcinogen MetabolismEnzyme KineticsMetabolism VariabilityMetabolite KineticsBiological MonitoringDrug Metabolism PhenotypingDrug Metabolism PolymorphismsDrug Metabolism VariationMetabolic Pathway PolymorphismsMetabolism Enzyme PolymorphismsN-acetyltransferase 2 PolymorphismN-acetyltransferase-mediated Metabolism
Hydrazine (N2H4), which has been categorized as a weak carcinogen, is a chemical with the one of the largest production rates in Japan. We have investigated the effects of acetylation phenotypes on the metabolism of hydrazine. Genotypes of N-acetyl transferases, NAT2*, were determined using polymerase chain reaction for 297 male workers. Biological and exposure monitoring were also conducted. The rapid and intermediate acetylators accounted for 45% each, and the slow acetylators accounted for 10%. Biological half-lives were significantly different among the three acetylation phenotypes (analysis of variance, P < 0.05): 3.94+/-1.70 hours for slow acetylators, 2.25+/-0.37 hours for intermediate acetylators, and 1.86+/-0.67 hours for rapid acetylators. Among Japanese, rapid and intermediate acetylators are the major phenotypes, which is in sharp contrast with those among Caucasians. We conclude that biological monitoring should take genetic factors, which may vary dramatically among different populations, into account.
13
Epidemiology of Bladder Cancer
Debra T. Silverman, Patricia Hartge, Alan S. Morrison et al. · Hematology/Oncology Clinics of North America · 1992 · 292 citations
Acetylation phenotype in colorectal carcinoma.
Kenneth F. Ilett, Beverley M. David, P Detchon et al. · PubMed · 1987 · 240 citations
Medicine, Oncology, Pharmacology +11